Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Net Margin 2024–2025
Current and historical net profit margin for Cyclacel Pharmaceuticals, Inc. (BGMS) over the last 10 years. The current net profit margin for Cyclacel Pharmaceuticals, Inc. as of December 31, 2025 is -401.34%.
From: 12/31/2024To: 12/31/2025
Revenue
Net Income
Net Margin
Cyclacel Pharmaceuticals, Inc. Net Margin — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) net margin over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclacel Pharmaceuticals, Inc.'s net margin?
Cyclacel Pharmaceuticals, Inc. (BGMS) reported net margin of -401.3% for fiscal 2025.
Where can I see BGMS's net margin history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s net margin by year and by quarter, including the growth rate.